Read the latest RCOphth news updates and guidance here.
The RCOphth has received requests for advisers to sit on the following consultant advisory appointment committees. Members, with at least one year’s experience as a consultant, are able to support these requests. All interviews will be virtual unless the trust has called for an in-person interview.
In a recent interview with BBC Wales, Gwyn Williams warned that a ‘tide of avoidable blindness’ could sweep Wales if eye care services are not reformed. He went on to say that waits for key treatments were ‘the biggest they've ever been’.
Nearly 600,000 people were waiting for ophthalmology treatments in January 2022, the largest waiting list of all NHS specialities, and around 10 per cent of all those on the referral-to-treatment pathway.
The General Medical Council (GMC) is consulting on revising its Good Medical Practice guidance, which is key to appraisal and revalidation. This article explains what the implications of this are and how you can share your views.
Letters have been sent recently to NHS organisations across England and the devolved administrations encouraging them to continue to look favourably on requests from doctors seeking their support to undertake national or regional work for the wider benefit of the public, and of health services.
With the number of people living with glaucoma in the UK expected to increase by almost a third between 2020 and 2035, Glaucoma UK is urging people to get their eyes tested. As part of Glaucoma Awareness Week 2022, which will run from 27 June to 3 July, the charity is highlighting the importance of regular sight tests, commonly referred to as eye tests, with the aim of ending preventable glaucoma sight loss.
The Royal College of Ophthalmologists’ President Bernie Chang is guest speaker at the prestigious keynote speech, The George Giles Memorial Lecture, at Optometry Tomorrow 2022.
Earlier this month, the first-ever Holyrood Eye Health Day was held in the Scottish Parliament in Edinburgh. This was a great opportunity to highlight the challenges facing ophthalmology services in Scotland to Members of the Scottish Parliament (MSPs) and the Scottish Government.
Faricimab is administered as an eye injection and is being recommended as an option for treating some adults with wet age-related macular degeneration (AMD) or with diabetic macular oedema (DMO).
Wales has had many problems with the delivery of effective eye care services for a long time, made a lot worse by the challenges of the Covid pandemic, exacerbating backlogs which are potentially putting patient care at risk. The Pyott Report provides recommendations to improve services.
